Clinical Trial

Vaginal Detection of Orally Delivered Probiotic Strains in Healthy Women

Study acronym: VSS2
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the present study is to obtain more information on the transit of orally ingested probiotics to the vagina.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-17; most recent amendment 2026-06-16.
Trial Details
NCT Number NCT07246161
Lead Sponsor Lallemand Health Solutions
Conditions Focus is on Healthy Subjects
Enrollment 72 participants
Start Date 2025-10-20
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-06-18